LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 173

Search options

  1. Article ; Online: Combining PARP Inhibitor With Immunotherapy-Does the Promise of Preclinical Data Translate to Clinic?

    Thawani, Rajat / Kummar, Shivaani

    JAMA oncology

    2022  Volume 9, Issue 1, Page(s) 25–27

    MeSH term(s) Humans ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Antineoplastic Agents/pharmacology ; Immunotherapy/adverse effects
    Chemical Substances Poly(ADP-ribose) Polymerase Inhibitors ; Antineoplastic Agents
    Language English
    Publishing date 2022-12-26
    Publishing country United States
    Document type Editorial ; Comment
    ISSN 2374-2445
    ISSN (online) 2374-2445
    DOI 10.1001/jamaoncol.2022.4591
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The evolving paradigm of cancer trials.

    Kummar, Shivaani

    Nature reviews. Drug discovery

    2017  Volume 17, Issue 4, Page(s) 225–226

    MeSH term(s) Antineoplastic Agents/therapeutic use ; Clinical Trials as Topic ; Humans ; Neoplasms/drug therapy
    Chemical Substances Antineoplastic Agents
    Language English
    Publishing date 2017-12-22
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2062954-0
    ISSN 1474-1784 ; 1474-1776
    ISSN (online) 1474-1784
    ISSN 1474-1776
    DOI 10.1038/nrd.2017.210
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Combining Poly (ADP-Ribose) Polymerase (PARP) Inhibitors with Chemotherapeutic Agents: Promise and Challenges.

    Thein, Kyaw Zin / Thawani, Rajat / Kummar, Shivaani

    Cancer treatment and research

    2023  Volume 186, Page(s) 143–170

    Abstract: Better understanding of molecular drivers and dysregulated pathways has furthered the concept of precision oncology and rational drug development. The role of DNA damage response (DDR) pathways has been extensively studied in carcinogenesis and as ... ...

    Abstract Better understanding of molecular drivers and dysregulated pathways has furthered the concept of precision oncology and rational drug development. The role of DNA damage response (DDR) pathways has been extensively studied in carcinogenesis and as potential therapeutic targets to improve response to chemotherapy or overcome resistance. Treatment with small molecule inhibitors of PARP has resulted in clinical response and conferred survival benefit to patients with ovarian cancer, BRCA-mutant breast cancer, HRD-deficient prostate cancer and BRCA-mutant pancreatic cancer, leading to US Food and Drug Administration (FDA) approvals. However, the observed clinical benefit with single agent PARP inhibitors is limited to few tumor types within the relevant genetic context. Since DDR pathways are essential for repair of damage caused by cytotoxic agents, PARP inhibitors have been evaluated in combination with various chemotherapeutic agents to broaden the therapeutic application of this class of drugs. In this chapter, we discuss the combination of PARP inhibitors with different chemotherapeutics agents, clinical experience to date, lessons learnt, and future directions for this approach.
    MeSH term(s) Female ; Humans ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Poly(ADP-ribose) Polymerases/metabolism ; Poly(ADP-ribose) Polymerases/therapeutic use ; Ribose/therapeutic use ; Precision Medicine ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Ovarian Neoplasms
    Chemical Substances Poly(ADP-ribose) Polymerase Inhibitors ; Poly(ADP-ribose) Polymerases (EC 2.4.2.30) ; Ribose (681HV46001) ; Antineoplastic Agents
    Language English
    Publishing date 2023-11-17
    Publishing country United States
    Document type Journal Article
    ISSN 0927-3042
    ISSN 0927-3042
    DOI 10.1007/978-3-031-30065-3_9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Gastric cancer: Geographic differences in multidisciplinary management.

    Kummar, Shivaani

    Current problems in cancer

    2015  Volume 39, Issue 6, Page(s) 314

    MeSH term(s) Combined Modality Therapy/methods ; Humans ; Stomach Neoplasms/therapy
    Language English
    Publishing date 2015-11
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 441816-5
    ISSN 1535-6345 ; 0147-0272
    ISSN (online) 1535-6345
    ISSN 0147-0272
    DOI 10.1016/j.currproblcancer.2015.11.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Increasing patient participation in oncology clinical trials.

    Chen, Jie / Lu, Ying / Kummar, Shivaani

    Cancer medicine

    2022  Volume 12, Issue 3, Page(s) 2219–2226

    Abstract: Aim: Timely recruitment of eligible participants is essential for the success of clinical trials, with insufficient accrual being the leading cause for premature termination of both oncology and non-oncology trials.: Methods: In this paper we further ...

    Abstract Aim: Timely recruitment of eligible participants is essential for the success of clinical trials, with insufficient accrual being the leading cause for premature termination of both oncology and non-oncology trials.
    Methods: In this paper we further elaborate on the challenges for patient participation in oncology trials from physician, patient, healthcare system, and some trial-related perspectives.
    Results: We present strategies such as use of digital healthcare technologies, real-world data and real-world evidence, decentralized clinical trials, pragmatic trial designs, and supportive services to increase patient participation.
    Conclusions: Multifaceted measures are necessary to increase patient participation, especially for those who are under-represented in cancer trials.
    MeSH term(s) Humans ; Patient Selection ; Patient Participation ; Neoplasms ; Medical Oncology ; Physicians
    Language English
    Publishing date 2022-08-31
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural
    ZDB-ID 2659751-2
    ISSN 2045-7634 ; 2045-7634
    ISSN (online) 2045-7634
    ISSN 2045-7634
    DOI 10.1002/cam4.5150
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Paraneoplastic neurologic manifestations of malignancies. Foreword.

    Kummar, Shivaani

    Current problems in cancer

    2014  Volume 38, Issue 4, Page(s) 114

    MeSH term(s) Humans ; Paraneoplastic Syndromes, Nervous System
    Language English
    Publishing date 2014-07
    Publishing country United States
    Document type Introductory Journal Article
    ZDB-ID 441816-5
    ISSN 1535-6345 ; 0147-0272
    ISSN (online) 1535-6345
    ISSN 0147-0272
    DOI 10.1016/j.currproblcancer.2014.08.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: These tumors can be associated with known genetic syndromes, such as the von Hippel-Lindau or multiple endocrine neoplasia 2 syndromes, or they can arise sporadically. Foreword.

    Kummar, Shivaani

    Current problems in cancer

    2014  Volume 38, Issue 1, Page(s) 6

    MeSH term(s) Adrenal Gland Neoplasms/etiology ; Humans ; Paraganglioma/etiology ; Pheochromocytoma/etiology
    Language English
    Publishing date 2014-01
    Publishing country United States
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 441816-5
    ISSN 1535-6345 ; 0147-0272
    ISSN (online) 1535-6345
    ISSN 0147-0272
    DOI 10.1016/j.currproblcancer.2014.02.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Tissue-Agnostic Drug Development: A New Path to Drug Approval.

    Thein, Kyaw Z / Lemery, Steven J / Kummar, Shivaani

    Cancer discovery

    2021  Volume 11, Issue 9, Page(s) 2139–2144

    Abstract: In recent years, there has been remarkable progress in our understanding of cancer biology, host responses, and the concept of precision oncology. These advances have focused attention on biomarker-driven, tissue-agnostic drug development strategies. The ...

    Abstract In recent years, there has been remarkable progress in our understanding of cancer biology, host responses, and the concept of precision oncology. These advances have focused attention on biomarker-driven, tissue-agnostic drug development strategies. The recent approvals by the FDA of pembrolizumab for the treatment of unresectable or metastatic, microsatellite instability-high or deficient mismatch repair solid tumors, and more recently for the treatment of tumor mutational burden-high tumors; and of larotrectinib and entrectinib for the treatment of neurotrophic tyrosine kinase (
    MeSH term(s) Drug Agonism ; Drug Approval ; Humans ; Neoplasms/drug therapy ; Neoplasms/genetics ; Precision Medicine ; United States ; United States Food and Drug Administration
    Language English
    Publishing date 2021-08-31
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2625242-9
    ISSN 2159-8290 ; 2159-8274
    ISSN (online) 2159-8290
    ISSN 2159-8274
    DOI 10.1158/2159-8290.CD-21-0554
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Current Problems in Cancer. Bone tumors in children and young adults. Foreword.

    Kummar, Shivaani

    Current problems in cancer

    2013  Volume 37, Issue 4, Page(s) 159

    MeSH term(s) Adolescent ; Adult ; Bone Neoplasms/therapy ; Child ; Child, Preschool ; Humans ; Young Adult
    Language English
    Publishing date 2013-07
    Publishing country United States
    Document type Introductory Journal Article
    ZDB-ID 441816-5
    ISSN 1535-6345 ; 0147-0272
    ISSN (online) 1535-6345
    ISSN 0147-0272
    DOI 10.1016/j.currproblcancer.2013.07.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Molecular insights into desmoid tumors.

    Bui, Nam / Kummar, Shivaani

    Oncotarget

    2017  Volume 8, Issue 53, Page(s) 90608–90609

    Language English
    Publishing date 2017-10-31
    Publishing country United States
    Document type Editorial
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.21293
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top